In animal models, even low stimulation currents can sometimes still cause electrographic seizures, researchers found.

PhD student Oscar Molina seeks new ways to assemble proteins into targeted cancer therapies, while also encouraging his fellow first-generation graduate students.

MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells.

By unraveling the genetic pathways that help Toxoplasma gondii persist in human cells, Sebastian Lourido hopes to find new ways to treat toxoplasmosis.

Fasting helps intestinal stem cells regenerate and heal injuries but also leads to a higher risk of cancer in mice, MIT researchers report.

Professor Ellen Roche is creating the next generation of medical devices to help repair hearts, lungs, and other tissues.

The new device, which can be implanted under the skin, rapidly releases naloxone when an overdose is detected.

Professor who uses a cross-disciplinary approach to understand human diseases on a molecular and cellular level succeeds Elazer Edelman.

A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.

The company that brought you no-stick toothpaste is moving into the medical space, with a lubricant for ostomy pouches and other products that could improve millions of lives.

The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.

The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.

Propofol, a drug commonly used for general anesthesia, derails the brain’s normal balance between stability and excitability.

More accurate uncertainty estimates could help users decide about how and when to use machine-learning models in the real world.

Staff members receive recognition for their exceptional support of the MIT community.

While women and men self-reported similar vaccination rates, unvaccinated women had less intention to get vaccinated than men.

A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.

A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.

By helping microbes withstand industrial processing, the method could make it easier to harness the benefits of microorganisms used as medicines and in agriculture.

This tiny, biocompatible sensor may overcome one of the biggest hurdles that prevent the devices from being completely implanted.

The minimally invasive, 3d-printable device offers safer application and removal, along with improved bioelectronic performance.

These models, which can predict a patient’s race, gender, and age, seem to use those traits as shortcuts when making medical diagnoses.

By designing new tools that can analyze huge libraries of immune cells and their targets, Michael Birnbaum hopes to generate better T cell therapies for cancer and other diseases.

A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.

The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.

Three innovations by an MIT-based team enable high-resolution, high-throughput imaging of human brain tissue at a full range of scales, and mapping connectivity of neurons at single-cell resolution.

Leuko, founded by a research team at MIT, is giving doctors a noninvasive way to monitor cancer patients’ health during chemotherapy — no blood tests needed.

Co-hosted by the McGovern Institute, MIT Open Learning, and others, the symposium stressed emerging technologies in advancing understanding of mental health and neurological conditions.

Twelve finalists participated in initiative and 2023-24 MIT-Royalty Pharma Prize Competition, designed to support female biotech pioneers.

The MITx MicroMasters in Data, Economics, and Design of Policy program educates learners around the world using its data-driven approach to poverty alleviation.

In the new economics course 14.163 (Algorithms and Behavioral Science), students investigate the deployment of machine-learning tools and their potential to understand people, reduce bias, and improve society.

By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.

New research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.

An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.

An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.

Honing her values and career path through her D-Lab classes, the MIT senior sets her sights on leveling inequalities in global health.

Fifteen new faculty members join six of the school’s academic departments.

New adhesive hydrogel coatings could prolong the lifespan of pacemakers, drug delivery depots, and other medical devices.

Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.

Ashutosh Kumar, a materials science and engineering PhD student and MathWorks Fellow, applies his eclectic skills to studying the relationship between bacteria and cancer.

A microneedle patch that delivers immune-regulating molecules can teach T cells not to attack hair follicles, helping hair to regrow.

New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.

Immunai’s founders were researchers at MIT when they launched their company to help predict how patients will respond to new treatments.

In MIT’s 2024 Killian Lecture, chemical engineer Paula Hammond described her groundbreaking work on nanoparticles designed to attack tumor cells.

MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.

Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.

With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.

The technology could offer a cheap, fast way to test for PFAS, which have been linked to cancer and other health problems.

Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.

A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.